par WorldTribune Personnel16 mars 2023 Des poursuites ont été intentées et une enquête criminelle est ouverte sur la base d’accus…
All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name (desk…
·新冠抗病毒药要起作用，不仅需要这个药物本身能有效抑制新冠病毒，也需要在关键器官，如呼吸系统等处，达到抑制新冠病毒所需的药物浓度。因此，当考虑递送一个药物的方式时，我们需要思考这个药物本身的分子特征是什么，不同递送方式下，人体会如何吸收这个分子，最后能不能抵…
Compendio SciCheck Está demostrado que Paxlovid, la píldora antiviral de Pfizer para el COVID-19, previene el COVID-19 grave y…
Remdesivir fue el primer medicamento aprobado para el tratamiento de COVID-19 y uno de los más caros.
How a twice-shelved drug became the standard of care for the most widespread disease Remdesivir was the first medication…
SciCheck Digest Paxlovid, Pfizer’s COVID-19 antiviral pill, has been shown to prevent severe COVID-19 and death.
SciCheck Digest Paxlovid, Pfizer’s COVID-19 antiviral pill, has been shown to prevent severe COVID-19 and death.
If the COVID shots are as bad as they appear, why isn’t your doctor warning you about all their potential side effects instead…
There’s a very simple reason why medical professionals such as Dr Peter McCullough and Dr Aseem Malhotra have become familiar…
All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner…
Jusqu’à présent, tous les médicaments développés contre le COVID-19 ont été désastreux d’une manière ou d’une autre.
It’s not easy being a regular multi-billionaire. Bill Gates used to be the simple guy-in-the-mansion next door, worried about…
The U.S. Food and Drug Administration has expanded its approval of the COVID-19 treatment remdesivir to include children…
Special Reports > Exclusives False claims made during senator's hearing that featured "disinformation docs" by Kristina Fiore…
Adam Roger s 05.24.2021 08:00 AM Some studies are too small. Some are too pharma.
Soon after the start of the second wave of COVID-19 pandemic in India, the images of people standing in long queues outside the…
Soon after the start of the second wave of COVID-19 pandemic in India, the images of people standing in long queues outside the…
इस महामारी ने एक बार फिर से हमें आगाह किया है कि भारत की स्वास्थ्य सेवाओं को और मज़बूत किए जाने की ज़रूरत है.
Soon after the start of the second wave of COVID-19 pandemic in India, the images of people standing in long queues outside the…
The COVID-19 pandemic brought the world to its knees with its sheer virulence and adaptive ability.
Cipla Doubles Remdesivir Production In India For "Unprecedented" Demand The COVID-19 pandemic brought the world to its knees…
What do virgin coconut oil (VCO), lianhua qingwen, convalescent plasma, tocilizumab, colchicine, rhinovirus, and ivermectin…
# While clinical trials suggest 'remdesivir' is not very effective in treating Covid-19, recent studies have shown that it does…
Mit einer dreiteiligen Chronik blicken wir auf dieses Corona-Jahr. Teil 1: Ausbruch in Wuhan, erster Fall in Deutschland und…
PandemicWHO Trial Finds No Benefit of 4 Drugs for Hospital COVID Patients Published 4 December 2020 None of the four once-promisi…
L'Union européenne est pointée du doigt par plusieurs députés et autres personnalités pour avoir acheté à prix d'or le remdésivir…
Viele EU-Länder haben sich mit dem vermeintlichen Covid-Medikament Remdesivir eingedeckt.
La commission européenne a conclu début octobre un «contrat cadre» avec le laboratoire Gilead visant à assurer la disponibilité…
El 10 de enero, cuando el SARS-CoV-2 apenas había salido de Wuhan, un artículo científico apuntaba a que un fármaco antiviral…
Regulation Nov 20, 2020 | 12:28 AM GMT The WHO’s new guidance counters FDA’s October approval of Gilead’s Veklury for…
Donald Trump’s brief stay in hospital in early October raised awareness – once again – of the variety of treatments being…
By Mary Beth Pfeiffer He is 57 years old with mild asthma, hypertension and atherosclerotic cardiovascular disease.
Donald Trump’s brief stay in hospital in early October raised awareness – once again – of the variety of treatments being…
October was a good month for Gilead Sciences, the giant manufacturer of antivirals headquartered in Foster City, California.
Article original paru dans ScienceMag. Il fait suite à une série d’articles parus dans FranceSoir sur la toxicité du remdesivir…
Donald Trump’s brief stay in hospital in early October raised awareness—once again—of the variety of treatments being…
Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
Gilead Sciences chairman and CEO Daniel O’Day Eight months after it was first tested in human patients at the center of the…
Donald Trump’s brief stay in hospital in early October raised awareness – once again – of the variety of treatments being…
On Thursday 22nd October, the to treat patients with COVID-19 who have been hospitalised.
Follow all of, including,, and a. This post has been updated. The hunt for pharmaceutical weapons to help beat the has (and a…
Follow all of PopSci’s COVID-19 coverage here, including tips on cleaning groceries, ways to tell if your symptoms are just…
On Thursday, October 22, the Food and Drug Administration approved remdesivir to treat patients with COVID-19 who have been…
BUENOS AIRES, ARGENTINA – APRIL 28: Biochemist Daniela Beatriz Ori manipulates swab samples to make a real time polymerase…
Nine months into the pandemic, this is what we know so far Donald Trump’s brief stay in hospital in early October raised…
Nine months into the pandemic, this is what we know so far Donald Trump’s brief stay in hospital in early October raised…
Nine months into the pandemic, this is what we know so far Donald Trump’s brief stay in hospital in early October raised…
Want the best Nottingham news by 9am every day? Sign up to our newsletter! Subscribe When you subscribe we will use the…
Nine months into the pandemic, this is what we know so far Donald Trump’s brief stay in hospital in early October raised…
Credit: PongMoji/Shutterstock Donald Trump's brief stay in hospital in early October raised awareness—once again—of the variety…
– By Gordon Dent, Senior Lecturer in Pharmacology, Keele University Donald Trump’s brief stay in hospital in early October…
View photos Donald Trump’s brief stay in hospital in early October raised awareness – once again – of the variety of treatments…
Donald Trump’s brief stay in hospital in early October raised awareness – once again – of the variety of treatments being…
The interim results of the World Health Organization’s massive Solidarity Therapeutics Trial are in — and they don’t bode well…
Итак, регистрационные удостоверения на отечественный и импортный ремдесивиры выданы.
Summary A broad and diverse effort is underway by biotech companies to solve the terrible riddle of the Coronavirus.
Please note that the text below is not a full transcript and has not been copyedited.
New Delhi: US President Donald Trump, who tested positive for Covid-19 last week, is being administered Remdesivir, an…
New Delhi: US President Donald Trump, who tested positive for Covid-19 last week, is being administered Remdesivir, an…
© Gilead It was beyond strange when the major media networks began to attack a pharmaceutical, especially in the middle of a…
« Des chercheurs qui cherchent, on en trouve. Des chercheurs qui trouvent, on en cherche.
LIJEKOVI i cjepiva za covid-19 intenzivno se istražuju, no za većinu zaraženih to zasad ne znači puno.
Anyone can publish on Medium per our Policies, but we don’t fact-check every story.
A lab technician sorts blood samples for a COVID-19 study. Researchers have been working furiously to identify medications and…
Jammi Nagaraj Rao, a public health physician and epidemiologist in the United Kingdom, has scanned through approximately 477…
Improvement seen with 5-day course, but clinical benefit uncertain In a randomized open-label trial involving close to 600…
Remdesivir es todo lo famoso, popular y celebrado que puede llegar a ser un medicamento.
Remdesivir may not be effective in treating moderate cases of the novel coronavirus, a new study finds.
Infectious Disease > COVID-19 But why have three trials produced three different results, experts wonder Hospitalized COVID-19…
Remdesivir may not be effective in treating moderate cases of the novel coronavirus, a new study finds.
Remdesivir may not be effective in treating moderate cases of the novel coronavirus, a new study finds.
Remdesivir may not be effective in treating moderate cases of the novel coronavirus, a new study finds.
Remdesivir may not be effective in treating moderate cases of the novel coronavirus, a new study finds.
The problem is that traditionally there has been poor scrutiny of clinical trials in India where often the emphasis is on…
La pandémie de Covid-19 continue de faire des victimes partout dans le monde et les premiers candidats vaccins ne devraient pas ê…
Image Credit:Corona Borealis Studio/Shutterstock.com In June 2020, engineers at the University of California San Diego…
AFP via Getty Images As the World Health Organization (WHO) baldly reminds us, “there are no specific vaccines or treatments…
I vaccini non sono l'unico oggetto della ricerca di strategie per contrastare Covid-19.
Two weeks ago, news came out that the United States has secured the entire current global supply of remdesivir, one of the two…
An editorial in a leading medical journal criticizes governments, academic institutions, and the media for failing to…
Remdesivir costs around Rs 5,000 per vial with a total treatment cost in the range of Rs 35,000-50,000 Topics Coronavirus…
Photo: Anna Shvets/Pexels. The Central Drugs Standard Control Organisation (CDSCO) has approved five drugs in the last month…
(Bloomberg Opinion) -- For months, hospitals have suffered the consequences of the country’s pandemic blunders.
Pharma company Gilead says the findings, though important, still need to be confirmed through further clinical trials.
Das Gesundheitsministerium hält nichts von Zwangslizenzen für das Coronamittel Remdesivir.
Remdesivir is now being manufactured by Cipla, Hetero Labs and Mylan. Cipla Wednesday launched the drug under the brand name…
En la carrera de fondo por encontrar un fármaco contra el SARS-CoV-2 todo cambia en cuestión de días.
En la carrera de fondo por encontrar un fármaco contra el SARS-CoV-2 todo cambia en cuestión de días.
Mientras la lista de tratamientos prometedores contra la COVID-19 parece aumentar cada semana, los investigadores tienen claro…
To beat the coronavirus pandemic, countries need to collaborate. We need the best possible science to develop vaccines and drugs…